Home›People›Paul Castella
Paul Castella

Paul Castella

Executive Chairman at Hera Biotech. Also a chairman and CFO at Innovative Trauma Care.

ExecutiveDirectorPublic companyRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Sep 23, 2026·Suggest an edit

About Paul Castella

Paul Castella is an executive chairman at Hera Biotech.

Form D filings also name Paul Castella as a chairman and CFO at Innovative Trauma Care.

Paul Castella reports to the SEC as a director of 1 public company: InventaBioTech (INVB).

Paul Castella first appears on SEC filings in 2018.

Experience

This experience comes from Paul Castella's profile and from SEC filings. For roles taken from filings, the years are when the filings name Paul Castella in the role, so the role may have started earlier or lasted longer.

Hera Biotech, Inc. Current
Co-Founder, Executive Chairman
2020 – Present · San Antonio, TX
Hera Biotech develops diagnostic tests for clinicians treating endometriosis and cervical conditions.
Innovative Trauma Care Inc. Current
Chairman and CFO
Executive Chairman (2013 – Present)
2013 – Present · San Antonio, TX
StemBioSys Current
Board member
2013 – Present
Xenotope Diagnostics, Inc. Current
Co-founder, President & CEO
2001 – Present
Targeted Technology Fund II
Senior Managing Partner
2013 – 2024
Bluegrass Vascular Technologies, Inc.
Chairman
2023
Targeted Technology Fund I
Managing Partner
2009 – 2022
Soluble Therapeutics, Inc.
Board member
2012 – 2020
BioDtech
Board member
2010 – 2020
Santalis Pharmaceuticals
Co-founder, CEO
2011 – 2019
ViroXis Corporation
Co-founder, CEO
2005 – 2019
InventaBioTech Inc.
Director
2018 · Public company (INVB)
BiO2 Medical, Inc.
Co-founder, President & CFO
2006 – 2012
CardioSpectra, Inc
Co-founder, President, CFO
2005 – 2008

Key Colleagues at Startups

The people Paul Castella works with at each company, as listed on that company's latest Form D.

Hera Biotech, Inc. · Form D/A, Sep 23, 2026
Wendy Smith
Wendy Smith
Board Member
Teo Tijerina
Teo Tijerina
Board Member
Somer Baburek
Somer Baburek
President, CEO, & Board Member
Innovative Trauma Care Inc. · Form D, Jan 3, 2025
DS
David Schneider
Executive officer and director
JT
Jim Traa
Director
JP
John Pinsent
Director
MP
Maggie Pemberton
Executive officer
JB
Joe Brennan
Director

Sources

  1. SECHera Biotech, Inc. Form D/A, filed Sep 23, 2026
  2. SECInnovative Trauma Care Inc. Form D, filed Jan 3, 2025
  3. SECForms 3, 4 and 5 filed by Paul Castella (SEC filer 1738846)